The ACIRA Registry: A Regional Tool to Improve the Healthcare Pathway for Patients Undergoing Percutaneous Coronary Interventions and Coronary Angiographies in the French Aquitaine Region: Study Design and First Results.
Acute Coronary Syndrome
/ diagnostic imaging
Aged
Angina, Stable
/ diagnostic imaging
Angina, Unstable
/ diagnostic imaging
Coronary Angiography
Coronary Artery Disease
/ diagnostic imaging
Critical Pathways
Female
France
Hospital Mortality
Humans
Male
Mortality
Myocardial Infarction
/ diagnostic imaging
Patient Readmission
Percutaneous Coronary Intervention
Prospective Studies
Registries
Journal
Critical pathways in cardiology
ISSN: 1535-2811
Titre abrégé: Crit Pathw Cardiol
Pays: United States
ID NLM: 101165286
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
pubmed:
1
10
2019
medline:
5
8
2021
entrez:
1
10
2019
Statut:
ppublish
Résumé
In France, there is a lack of information about practices and pathways of coronary angiographies and percutaneous coronary interventions (PCI). We present the design and the first results of the ACIRA registry, the goal of which is to answer questions about quality, security, appropriateness, efficiency of, and access to interventional cardiology (IC) healthcare pathway in the French Aquitaine region. The ACIRA registry is an on-going, multicenter, prospective, exhaustive, scalable, and nominative cohort study of patients who undergo coronary angiographies or percutaneous coronary intervention in any of the catheterization laboratories. The data related to hospitalizations and procedures are directly extracted from hospital information systems. In-hospital mortality, readmissions, and cardiovascular morbidity are collected from the French hospital medical information system database. An identity management system has been implemented to create the patient health care pathway. From January 1, 2012, to June 30, 2018, 147,136 procedures performed on 106,005 patients have been included in the ACIRA registry. ACIRA has shown its ability to study the patient IC healthcare pathway, up to 1 year after the procedure. Nominative data enable the linkage between clinical and medico-administrative databases and possible supplementary data collection. The use of existing databases allowed us to limit patients lost to follow-up, prevent the double entry of data, improve data quality, and reduce the operating costs. The prospect of linkage with the French National Health Data System may offer promising opportunities for future medical research projects and for developing collaboration and benchmarking with other IC registries abroad.
Sections du résumé
BACKGROUND
In France, there is a lack of information about practices and pathways of coronary angiographies and percutaneous coronary interventions (PCI). We present the design and the first results of the ACIRA registry, the goal of which is to answer questions about quality, security, appropriateness, efficiency of, and access to interventional cardiology (IC) healthcare pathway in the French Aquitaine region.
METHODS
The ACIRA registry is an on-going, multicenter, prospective, exhaustive, scalable, and nominative cohort study of patients who undergo coronary angiographies or percutaneous coronary intervention in any of the catheterization laboratories. The data related to hospitalizations and procedures are directly extracted from hospital information systems. In-hospital mortality, readmissions, and cardiovascular morbidity are collected from the French hospital medical information system database. An identity management system has been implemented to create the patient health care pathway.
RESULTS
From January 1, 2012, to June 30, 2018, 147,136 procedures performed on 106,005 patients have been included in the ACIRA registry.
CONCLUSIONS
ACIRA has shown its ability to study the patient IC healthcare pathway, up to 1 year after the procedure. Nominative data enable the linkage between clinical and medico-administrative databases and possible supplementary data collection. The use of existing databases allowed us to limit patients lost to follow-up, prevent the double entry of data, improve data quality, and reduce the operating costs. The prospect of linkage with the French National Health Data System may offer promising opportunities for future medical research projects and for developing collaboration and benchmarking with other IC registries abroad.
Identifiants
pubmed: 31567554
doi: 10.1097/HPC.0000000000000199
pii: 00132577-202003000-00001
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-8Références
Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788.
OECD/EU. Health at a Glance: Europe 2018: State of Health in the EU Cycle. 2018.Paris: OECD Publishing.
Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013;368:254–265.
Blankenship JC, Marshall JJ, Pinto DS, et al. Effect of percutaneous coronary intervention on quality of life: a consensus statement from the society for cardiovascular angiography and interventions. Catheter Cardiovasc Interv. 2013;81:243–259.
Epstein AJ, Polsky D, Yang F, et al. Coronary revascularization trends in the United States: 2001–2008. JAMA J Am Med Assoc. 2011;305:1769–1776.
OECD/EU. Health at a Glance: Europe 2016 – State of Health in the EU Cycle. 2016.Paris: OECD Publishing.
Schapiro-Dufour E. Utilisation des endoprothèses (stents) coronaires en France en 2014 : Étude à partir des données du SNIIRAM [Internet]. Paris, France: Haute Autorité de Santé, Agence nationale de sécurité du médicament et des produits de santé. Available at: https://www.has-sante.fr/upload/docs/application/pdf/2016-08/utilisation_des_endoprotheses-stents-coronaires_en_france_en_2014_etude_a_partir_des_donnees_du_sniiram.pdf. Accessed September 2019.
Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2019;14:1435–1534.
Patel MR, Calhoon JH, Dehmer GJ, et al.; Coronary Revascularization Writing Group. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 appropriate use criteria for coronary revascularization in patients with acute coronary syndromes: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 201769:570–591.
Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease : a report of the American college of cardiology appropriate use criteria task force, American Association for thoracic surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Nucl Cardiol. 2017;24:1759–1792.
OECD. Health at a Glance: Cardiac Procedures. 2015. Paris: OECD publishing; p110–111.
OECD. Geographic Variations in Health Care. 2014.Paris: OECD publishing.
A Study of Cost Variation for Percutaneous Coronary Interventions (Angioplasties) in the U.S. 2015. Available at: https://www.bcbs.com/sites/default/files/file-attachments/health-of-america-report/BCBS-HealthOfAmericaReport-StudyCostVariationForPCIs.pdf. Accessed September 2019.
Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart Br Card Soc. 2010;96:1617–1621.
SWEDEHEART. Swedeheart Annual report 2015. Available at: https://www.ucr.uu.se/swedeheart/dokument-sh/arsrapporter-sh/swedeheart-annual-report-2015/viewdocument. Accessed September 2019.
Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol. 2002;39:1096–1103.
Ludman PF; British Cardiovascular Intervention Society. British cardiovascular intervention society registry for audit and quality assessment of percutaneous coronary interventions in the United Kingdom. Heart. 2011;97:1293–1297.
Vogt A, Bonzel T, Harmjanz D, et al. PTCA registry of German community hospitals. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) Study Group. Eur Heart J. 1997;18:1110–1114.
Rangé G, Chassaing S, Marcollet P, et al. The CRAC cohort model: a computerized low cost registry of interventional cardiology with daily update and long-term follow-up. Rev Epidemiol Sante Publique. 2018;66:209–216.
Gilard M, Blanchard D, Helft G, et al.; STENTICO Investigators. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol. 2009;104:338–342.
Puymirat E, Blanchard D, Perier MC, et al. Study design and baseline characteristics of the national observational study of diagnostic and interventional cardiac catheterization by the French Society of Cardiology. Am J Cardiol.2013;112:336–342.
Spaulding C, Morice MC, Lancelin B, et al. Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. Eur Heart J. 2006;27:1054–1060.
Moulis G, Lapeyre-Mestre M, Palmaro A, et al. French health insurance databases: what interest for medical research? Rev Med Interne. 2015;36:411–417.
Rey G, Jougla E, Fouillet A, Hémon D, et al. Ecological association between a deprivation index and mortality in France over the period 1997 - 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health. 2009;9:33.
McAllister KSL, Ludman PF, Hulme W, et al. A contemporary risk model for predicting 30-day mortality following percutaneous coronary intervention in England and Wales. Int J Cardiol. 2016;210:125–132.
Gardner C, Rankin JM, Geelhoed E, et al. Evaluation of long-term clinical and health service outcomes following coronary artery revascularisation in Western Australia (WACARP): a population-based cohort study protocol. BMJ Open. 2014;4:e006337.
Patel N, De Maria GL, Kassimis G, et al. Outcomes after emergency percutaneous coronary intervention in patients with unprotected left main stem occlusion: the BCIS national audit of percutaneous coronary intervention 6-year experience. JACC Cardiovasc Interv. 2014;7:969–980.
Kutcher MA, Brennan JM, Rao SV, et al. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the national cardiovascular data registry. Catheter Cardiovasc Interv. 2014;83:171–181.
Fosbøl EL, Granger CB, Peterson ED, et al. Prehospital system delay in ST-segment elevation myocardial infarction care: a novel linkage of emergency medicine services and in hospital registry data. Am Heart J. 2013;165:363–370.
Dreyer NA, Garner S. Registries for robust evidence. JAMA. 2009;302:790–791.
Arts DGT, De Keizer NF, Scheffer GJ. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc. 2002;9:600–611.
Sariyar M, Borg A, Heidinger O, et al. A practical framework for data management processes and their evaluation in population-based medical registries. Inform Health Soc Care. 2013;38:104–119.
Health Data Hub: mission de préfiguration. [Internet]. Available at: https://solidarites-sante.gouv.fr/IMG/pdf/181012_-_rapport_health_data_hub.pdf. Accessed September 2019.
Cram P, House JA, Messenger JC, et al. Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®. Am Heart J. 2012;163:214.e1–221.e1.
Fokkema ML, James SK, Albertsson P, et al. Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention. 2016;12:303–311.
Lesaine E, Perez C, Legrand JP, et al. Utilisation d’un registre de pratiques pour le développement professionnel continu, le registre ACIRA et les angioplasties. Rev Epidemiol Sante Publique. 2014;62:S81.
Lesaine E, Coste P, Kret M, et al. Analyse du parcours de soins hospitalier des patients après un acte de cardiologie interventionnelle – Utilisation d’un registre de pratique et du PMSI Aquitaine. Rev Epidemiol Sante Publique. 2018;66:S183–S184.
Francis F, Lesaine E, Perez C, et al. Development and validation of an indicator of the appropriateness of coronary angiographies and percutaneous coronary interventions. 2018.In: International Improvement Science and Research Symposium. Amsterdam.
Tuppin P, Rudant J, Constantinou P, et al.; Value of a national administrative database to guide public decisions: from the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. Rev Epidemiol Sante Publique. 2017;65(suppl 4):S149–S167.
Nelson EC, Dixon-Woods M, et al. Patient focused registries can improve health, care, and science. BMJ. 2016;354:i3319.